Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,560 | -22,273 | -16,451 | -19,557 | -8,280 |
| Depreciation Amortization | 580 | 32 | 17 | 15 | 10 |
| Other Working Capital | 11 | -1,356 | -1,357 | 5,570 | 1,210 |
| Other Operating Activity | 587 | 12,979 | 460 | 503 | 600 |
| Operating Cash Flow | $-3,382 | $-10,618 | $-17,332 | $-13,468 | $-6,460 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -18 | -49 | -24 | -10 |
| Other Investing Activity | 0 | 0 | 1,185 | 466 | -1,430 |
| Investing Cash Flow | $-2 | $-18 | $1,136 | $442 | $-1,440 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,171 | N/A | N/A | N/A | N/A |
| Debt Repayment | -193 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 8,939 | 2,988 | 0 | N/A |
| Dividend Paid | N/A | N/A | -740 | -824 | -260 |
| Other Financing Activity | 99 | 9,205 | 5,470 | 13,653 | 13,840 |
| Financing Cash Flow | $3,078 | $18,143 | $7,717 | $12,830 | $13,580 |
| Beginning Cash Position | 980 | 1,263 | 9,742 | 9,938 | 4,260 |
| End Cash Position | 674 | 8,770 | 1,263 | 9,742 | 9,930 |
| Net Cash Flow | $-306 | $7,507 | $-8,479 | $-197 | $5,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,382 | -10,618 | -17,332 | -13,468 | -6,460 |
| Capital Expenditure | -2 | -18 | -49 | -24 | N/A |
| Free Cash Flow | -3,384 | -10,636 | -17,381 | -13,493 | -6,460 |